Rademacher M, Kuhn H, Borchert A
Int J Mol Sci. 2021; 22(15).
PMID: 34360557
PMC: 8345999.
DOI: 10.3390/ijms22157795.
Vernimmen D
PLoS Genet. 2014; 10(10):e1004668.
PMID: 25330308
PMC: 4199490.
DOI: 10.1371/journal.pgen.1004668.
Papetti M, Wontakal S, Stopka T, Skoultchi A
Cell Cycle. 2010; 9(10):1972-80.
PMID: 20495378
PMC: 3019278.
DOI: 10.4161/cc.9.10.11602.
He Z, Russell J
Blood. 2006; 109(2):795-801.
PMID: 17003365
PMC: 1785088.
DOI: 10.1182/blood-2006-06-027946.
Munugalavadla V, Dore L, Tan B, Hong L, Vishnu M, Weiss M
Mol Cell Biol. 2005; 25(15):6747-59.
PMID: 16024808
PMC: 1190349.
DOI: 10.1128/MCB.25.15.6747-6759.2005.
Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2.
Anguita E, Hughes J, Heyworth C, Blobel G, Wood W, Higgs D
EMBO J. 2004; 23(14):2841-52.
PMID: 15215894
PMC: 514941.
DOI: 10.1038/sj.emboj.7600274.
Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.
Ickowicz Schwartz D, Gozlan Y, Greenbaum L, Babushkina T, Katcoff D, Malik Z
Br J Cancer. 2004; 90(9):1833-41.
PMID: 15150593
PMC: 2409749.
DOI: 10.1038/sj.bjc.6601760.
Adaptive control methods for the dose individualisation of anticancer agents.
Rousseau A, Marquet P, DeBord J, Sabot C, Lachatre G
Clin Pharmacokinet. 2000; 38(4):315-53.
PMID: 10803455
DOI: 10.2165/00003088-200038040-00003.
Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
Rekhtman N, Radparvar F, Evans T, SKOULTCHI A
Genes Dev. 1999; 13(11):1398-411.
PMID: 10364157
PMC: 316770.
DOI: 10.1101/gad.13.11.1398.
An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.
Schiller J, Neuberg D, Burns D, Ritch P, Larson M, Levitt M
Invest New Drugs. 1997; 15(4):319-24.
PMID: 9547674
DOI: 10.1023/a:1005985418441.
Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential.
Arcangeli A, Carla M, Del Bene M, Becchetti A, Wanke E, Olivotto M
Proc Natl Acad Sci U S A. 1993; 90(12):5858-62.
PMID: 8516337
PMC: 46822.
DOI: 10.1073/pnas.90.12.5858.
Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells.
Shama S, Avni D, Frederickson R, Sonenberg N, Meyuhas O
Gene Expr. 1995; 4(4-5):241-52.
PMID: 7787416
PMC: 6134383.
Sp1 functions in a chromatin-dependent manner to augment human alpha-globin promoter activity.
Pondel M, Murphy S, Pearson L, Craddock C, Proudfoot N
Proc Natl Acad Sci U S A. 1995; 92(16):7237-41.
PMID: 7638173
PMC: 41314.
DOI: 10.1073/pnas.92.16.7237.
Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.
Melloni E, Pontremoli S, Michetti M, Sacco O, Cakiroglu A, Jackson J
Proc Natl Acad Sci U S A. 1987; 84(15):5282-6.
PMID: 3474654
PMC: 298839.
DOI: 10.1073/pnas.84.15.5282.
Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.
Steinheider G, Schaefer A, Westendorf J, Marquardt H
Cell Biol Toxicol. 1988; 4(1):123-33.
PMID: 3228706
DOI: 10.1007/BF00141291.
Relationship between transient DNA hypomethylation and erythroid differentiation of murine erythroleukemia cells.
Razin A, Levine A, Kafri T, Agostini S, Gomi T, CANTONI G
Proc Natl Acad Sci U S A. 1988; 85(23):9003-6.
PMID: 3194403
PMC: 282650.
DOI: 10.1073/pnas.85.23.9003.
Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind R
Proc Natl Acad Sci U S A. 1988; 85(11):3835-9.
PMID: 3163801
PMC: 280314.
DOI: 10.1073/pnas.85.11.3835.
Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
Marks P, Breslow R, Rifkind R, Ngo L, Singh R
Proc Natl Acad Sci U S A. 1989; 86(16):6358-62.
PMID: 2762329
PMC: 297838.
DOI: 10.1073/pnas.86.16.6358.
Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells.
Tanaka K, Kaufman S, Milstien S
Proc Natl Acad Sci U S A. 1989; 86(15):5864-7.
PMID: 2762302
PMC: 297731.
DOI: 10.1073/pnas.86.15.5864.
Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.
Marks P, Rifkind R
Environ Health Perspect. 1989; 80:181-8.
PMID: 2647479
PMC: 1567625.
DOI: 10.1289/ehp.8980181.
